AlanPollackMD

Radiation Oncology • Miami, FL

Professor of Radiation Oncology, University Miami School of Medicine

Join to view full profile

Dr. Pollack is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Pollack's full profile

Already have an account?

Office
1475 Nw 12th Ave
Suite 1500
Miami, FL 33136
Phone+1 305-243-4916

Fax+1 305-243-4363

Education & Training

University of Texas M D Anderson Cancer CenterResidency, Radiation Oncology, 1988 - 1992
University of Miami/Jackson Health SystemInternship, Internal Medicine, 1987 - 1988
University of Miami Leonard M. Miller School of MedicineClass of 1987

Certifications & Licensure

FL State Medical License 2008 - 2025
PA State Medical License 1991 - 2008
TX State Medical License 1992 - 2002
American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Super Doctor SuperDoctors.com

Clinical Trials

Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer Start of enrollment: 2009 Sep 01
Active, not recruiting
Phase 3
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer Start of enrollment: 2011 Dec 27
Completed
Not Applicable
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial Start of enrollment: 2011 Oct 31
Completed
Not Applicable
MRI-Mapped Dose-Escalated Salvage Radiotherapy Post-Prostatectomy: The MAPS Trial Start of enrollment: 2012 Jul 12
Active, not recruiting
Not Applicable
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer Start of enrollment: 2013 Apr 04
Recruiting
Not Applicable
Trial of Prostate Cancer Patients Undergoing Active Surveillance With or Without MRI-Guided Management Start of enrollment: 2012 Aug 01
Withdrawn
Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors Start of enrollment: 2011 Jun 08
Completed
Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy Start of enrollment: 2016 Jan 05
Terminated
Not Applicable
MRI Based Active Selection for Treatment Trial Start of enrollment: 2014 Nov 12
Active, not recruiting
Not Applicable
Randomized MRI-Guided Prostate Boosts Via Initial Lattice Stereotactic vs Daily Moderately Hypofractionated Radiotherapy Start of enrollment: 2015 Feb 05
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

Prognostic Significance of Immune Cell Infiltration in Muscle-invasive Bladder Cancer Treated with Definitive Chemoradiation: A Secondary Analysis of RTOG 0524 and RTO...
Zaker Rana, Sophia C Kamran, Amol C Shetty, Philip Sutera, Yang Song
European Urology Oncology. 2024-10-01
Evaluating 4Kscore's role in predicting progression on active surveillance for prostate cancer independently of clinical information and PIRADS score.
Helen Y Hougen, Isildinha M Reis, Sunwoo Han, Nachiketh Soodana Prakash, Jamie Thomas
Prostate Cancer and Prostatic Diseases. 2024-09-27
1 citations
Lipid Metabolism Modulatory Cisplatin Prodrug Sensitizes Resistant Prostate Cancer toward Androgen Deprivation Therapy.
Subham Guin, Akash Ashokan, Alan Pollack, Shanta Dhar
ACS Pharmacology & Translational Science. 2024-09-13

Press Mentions

Three Junior Faculty Members Join Sylvester Comprehensive Cancer Center’s K12 Faculty Scholars at Annual SymposiumJuly 25th, 2024
Sylvester Junior Faculty Selected for K12 Research GrantsMay 16th, 2023
Sylvester’s Course on Cancer Clinical Trials Goes National, InternationalFebruary 15th, 2023
Join now to see all